BRIEF published on 11/21/2025 at 08:03, 13 days 20 hours ago Société Générale: Update on the share buyback program Share Capital Société Générale Share Buyback General Assembly ECB Regulations
PRESS RELEASE published on 11/21/2025 at 07:58, 13 days 20 hours ago Societe Generale: New description of the share buy-back programme and report on the purchases performed Societe Generale announces the start of a EUR 1 billion share buy-back program for cancellation. As of 20 November 2025, 6.1% completed. New buy-backs to be based on updated program Share Buy-back Société Générale Financial Markets Programme Stock Repurchase
BRIEF published on 11/14/2025 at 17:46, 20 days 10 hours ago Shares and voting rights of Société Générale as of November 6, 2025 Voting Rights Société Générale Actions ESG European Bank
PRESS RELEASE published on 11/14/2025 at 17:41, 20 days 10 hours ago Societe Generale: shares and voting rights as of 6 November 2025 Societe Generale reports total number of voting rights and shares as of 6 November 2025 in compliance with French regulations Voting Rights Société Générale Shares French Regulations Financial Disclosure
BRIEF published on 10/30/2025 at 19:49, 1 month 5 days ago Prudential capital requirements for Société Générale in 2026 Société Générale CET1 Ratio Capital Requirements European Central Bank Pillar 2
PRESS RELEASE published on 10/30/2025 at 19:44, 1 month 5 days ago Societe Generale: Disclosure of regulatory capital requirements effective from 1 January 2026 The European Central Bank notifies Societe Generale Group of regulatory capital requirements effective from 1 January 2026, including CET1 ratio and Leverage Ratio P2R CET1 Ratio Société Générale Group European Central Bank Regulatory Capital Requirements Leverage Ratio P2R
BRIEF published on 10/30/2025 at 18:03, 1 month 5 days ago Societe Generale Updates Its 2025 Universal Registration Document Société Générale Regulatory Compliance Universal Registration ESG Integration French Financial Authority
PRESS RELEASE published on 10/30/2025 at 17:58, 1 month 5 days ago Societe Generale: Availability of the third amendment to the 2025 Universal Registration Document Societe Generale informs the public about the availability of the third amendment to the 2025 Universal Registration Document filed with the French Financial Markets Authority Société Générale AMF Financial Markets French Corporation 2025 Universal Registration Document
BRIEF published on 10/13/2025 at 18:00, 1 month 22 days ago Societe Generale continues its share buyback program Euronext Paris Share Capital Société Générale Share Buyback Market Abuse
PRESS RELEASE published on 10/13/2025 at 17:55, 1 month 22 days ago Societe Generale: Information regarding executed transactions within the framework of a share buy-back program Societe Generale provides details on executed transactions within a share buy-back program, meeting regulatory requirements. Over 92% of the program completed by 10 Oct 2025 Société Générale Regulatory Compliance Market Abuse Regulation Share Buy-back Program Executed Transactions
Published on 12/05/2025 at 02:35, 1 hour 58 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 33 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 28 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 33 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 3 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 43 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 8 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 18 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 23 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 33 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 48 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 49 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 32 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
